LIVINGSTON, NJ--(Marketwire - December 18, 2012) - [ Milestone Scientific Inc ]. (OTCQB: [ MLSS ]), the recognized leader in advanced, computer-controlled injection technologies, today announced that Christie Dental has rolled out Milestone's STA Single Tooth Anesthesia System across nearly all its dental practices in the Central Florida Region and expects to complete the deployment across the entire organization by the first quarter of 2013.

Dr. Tim Morris, DDS, co-owner of Christie Dental Practice Group, commented, "We have been introducing Milestone's painless injection system across the organization and have received very positive feedback from our patients. This is best illustrated by the number of patients who call to schedule appointments and specifically request the STA System.We have also seen increased referrals and reduced cancellations due to increased patient satisfaction.We have attracted new patients to our practice through a proactive marketing initiative around the technology. Working with Milestone and the STA System provides additional clinical benefits for our patients, including reduced complications associated with anesthesia and reduced waiting time for the onset of anesthesia. We look forward to implementing Milestone's painless injection system in all of our remaining offices."

Leonard Osser, Chief Executive Officer of Milestone Scientific, commented, "We are pleased to report an expansion in our Florida footprint with the addition of Christie Dental, a group dental practice with17 locations and 35 dentists throughout Central Florida. This latest agreement further validates our strategy of targeting group dental practices as a means to rapidly and cost effectively penetrate the domestic market."

About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering advanced computer-controlled drug delivery technologies for the medical and dental markets and currently sells its award-winning products through a global distribution network serving North and South America, Asia, Africa, Europe and the Middle East. For more information on the STA Single Tooth Anesthesia System instrument and other innovative Milestone products, please visit the Company's web site found at [ www.milestonescientific.com ].

SafeHarbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2011. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.